|
2081 |
UK and China enter agreement on medicines, devices
Enthalten in Reactions weekly Bd. 1689, 17.2.2018, Nr. 1, date:2.2018: 5
|
|
|
|
2082 |
UK's MHRA targets online sale of fake slimming pills
Enthalten in Reactions weekly Bd. 1682, 16.12.2017, Nr. 1, date:12.2017: 7
|
|
|
|
2083 |
Uncovering the emotional aspects of working on a clinical trial: a qualitative study of the experiences and views of staff involved in a type 1 diabetes trial
Enthalten in Trials Bd. 16, 7.1.2015, Nr. 1, date:12.2015: 1-11
|
|
|
|
2084 |
Understanding disease and illness
Enthalten in Theoretical medicine and bioethics Bd. 38, 13.7.2017, Nr. 4, date:8.2017: 239-244
|
|
|
|
2085 |
Understanding the null hypothesis (H0) in non-inferiority trials
Enthalten in Critical care Bd. 21, 6.5.2017, Nr. 1, date:12.2017: 1-2
|
|
|
|
2086 |
Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes
Enthalten in Diabetologia Bd. 60, 10.6.2017, Nr. 9, date:9.2017: 1782-1790
|
|
|
|
2087 |
US FDA requests hold on early clinical trials of atezolizumab
Enthalten in Reactions weekly Bd. 1671, 30.9.2017, Nr. 1, date:9.2017: 6
|
|
|
|
2088 |
Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network
Enthalten in Drugs - real world outcomes Bd. 4, 30.9.2017, Nr. 4, date:12.2017: 199-213
|
|
|
|
2089 |
Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study
Enthalten in BMC complementary and alternative medicine Bd. 17, 4.5.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
2090 |
Using regulatory enforcement theory to explain compliance with quality and patient safety regulations: the case of internal audits
Enthalten in BMC health services research Bd. 18, 30.1.2018, Nr. 1, date:12.2018: 1-6
|
|
Administration
